TICAM2 Recombinant antibody

TICAM2 Uni-rAbTM Recombinant Antibody for IF/ICC, ELISA
Cat No. 84064-6-RR
Clone No.241186C12

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IF/ICC, ELISA

TIR domain-containing adapter molecule 2, TICAM-2, TICAM 2, Putative NF-kappa-B-activating protein 502, MyD88-4

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IF/ICC detected inPC-3 cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:125-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

84064-6-RR targets TICAM2 in IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen Peptide Predict reactive species
Full Name toll-like receptor adaptor molecule 2
Calculated Molecular Weight 27 kDa
GenBank Accession NumberNM_021649
Gene Symbol TICAM2
Gene ID (NCBI) 353376
RRIDAB_3671634
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purfication
UNIPROT IDQ86XR7
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TICAM2, also named TIRAP3, TIRP, and TRAM, is involved in IL1-triggered NF-kappa-B activation, functioning upstream of IRAK1, IRAK2, TRAF6, and IKBKB. Physically bridges TLR4 and TICAM1 and functionally transmits LPS-TRL4 signal to TICAM1. TICAM2 is involved in LPS-TLR4 signaling to regulate the MYD88-independent pathway during the innate immune response to LPS.

Protocols

Product Specific Protocols
IF protocol for TICAM2 antibody 84064-6-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...